According to a hypothesis presented by Penntinen [57], an increased plasma IL-2 concentration brings about a reduction of bioavailability of insulin-like growth factor-1, by reducing the production of androgenic hormones, thus contributing to insulin resistance. The gene discussed is IGF1; the disease is Insulin resistance.